Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial.

Cardiovascular diabetology - 13 Jan 2025

Marwick Thomas H, Lam Carolyn, Liu Yuxi, Del Prato Stefano, Rosenstock Julio, Butler Javed, Ezekowitz Justin, Ibrahim Nasrien E, Tang W H Wilson, Zannad Faiez, Perfetti Riccardo, Januzzi James L

Abstract excerpt

BACKGROUND: Diabetic myocardial disorder (DbMD, evidenced by abnormal echocardiography or cardiac biomarkers) is a form of stage B heart failure (SBHF) at high risk for progression to overt HF. SBHF is defined by abnormal LV morphology and function and/or abnormal cardiac biomarker concentrations. OBJECTIVE: To compare the evolution of four DbMD groups based on biomarkers alone, systolic and diastolic dysfunction...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aldehyde Reductase
Share to Exercise Tolerance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Failure

Share to Natriuretic Peptide, Brain

Share to Peptide Fragments

Share to Troponin T

Share to Ventricular Dysfunction, Left

Share to Ventricular Function, Left

Source

Open in PubMed Open full text

Identifiers

PMID: 39806375
DOI: 10.1186/s12933-024-02554-y
PMCID: PMC11730511

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial.PMID 39806375Read ↗

Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.Semantic proximity Read ↗

WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.Semantic proximity Read ↗

Echocardiographic phenotypes of Chinese patients with type 2 diabetes may indicate early diabetic myocardial disease.Semantic proximity Read ↗

Diabetic cardiomyopathy: Clinical phenotype and practice.Semantic proximity Read ↗

Development and validation of a machine learning-based approach to identify high-risk diabetic cardiomyopathy phenotype.Semantic proximity Read ↗

Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.Semantic proximity Read ↗

Molecular Dysfunction and Phenotypic Derangement in Diabetic CardiomyopathySemantic proximity Read ↗

The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathySemantic proximity Read ↗

HFpEF as the Predominant and Underrecognized Heart Failure Phenotype in Type 2 Diabetes: Evidence from the DIABET-IC StudySemantic proximity Read ↗

Coexistent Diabetes Is Associated With the Presence of Adverse Phenotypic Features in Patients With Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Left ventricular myocardial molecular profile of human diabetic ischaemic cardiomyopathySemantic proximity Read ↗

Patients phenotypes and cardiovascular risk in type 2 diabetes: the Jackson Heart Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.